Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification (Q22241487)

inflammatory bowel diseases

Europe PubMed Central

title

Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification (English)

0 references

main subject

0 references

Iris Dotan

1

Iris

Dotan

1 reference

PubMed

PubMed publication ID

19072419

Expert Review of Gastroenterology & Hepatology

8 February 2023

language of work or name

English

0 references

publication date

December 2007

0 references

published in

0 references

volume

1

0 references

issue

2

0 references

page(s)

265-274

0 references

cites work

Indeterminate colitis: a significant subgroup of pediatric IBD.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Colonic bacteria express an ulcerative colitis pANCA-related protein epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surg

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Serological markers in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Risk factors for initial surgery in pediatric patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Identification of a novel bacterial sequence associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

The value of serologic markers in indeterminate colitis: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Autoantibodies as predictors of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Immune sensitization to food, yeast and bacteria in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Structure of beta-glucan oligomer from laminarin and its effect on human monocytes to inhibit the proliferation of U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Anti-neutrophil cytoplasmic antibodies in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

pANCA represents a cross-reactivity to enteric bacterial antigens

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Positive and negative predictive values: use of inflammatory bowel disease serologic markers

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Serum antibodies in first-degree relatives of patients with IBD: a marker of disease susceptibility? A follow-up pilot-study after 7 years

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

The effect of dietary yeast on the activity of stable chronic Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Seroreactivity againstSaccharomyces cerevisiaein patients with Crohn’s disease and celiac disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021

Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.265

7 January 2021